We look forward to welcoming you to the Annual Congress of the Schweizerische Ophthalmologische Gesellschaft (Schweizerische Ophthalmologische Gesellschaft (SOG-SSO) / Swiss Society of Ophthalmology in St. Gallen from August 28 to 30. You will find us at booth no. 23 together with our distribution partner VON HOFF AG. Aishwarya Sriram and Christoph Tschantré will show you neos™ and answer all your questions. You will have the opportunity to try neos™ and experience an automated neurophthalmic examination. We look forward to seeing you at SOG-SSO! #Opththalmology #Neurology #NeuroOphthalmology #Optometry #startupswitzerland
machineMD
Herstellung medizinischer Geräte
Berne, Berne 1.855 Follower:innen
Radically improving the measurement of brain function
Info
machineMD was founded by an interdisciplinary team with a shared vision for a world where patients receive an accurate, fast, and early diagnosis of brain disorders. Together with our global network of partners and medical experts, our mission is to radically improve the measurement of brain function. We combine Virtual Reality and Artificial Intelligence to empower ophthalmologists and neurologists with reliable measurements of eye and pupil movements. Our goal is to bring the diagnostic quality of highly trained tertiary care specialists where it is needed most, in primary and secondary care. 🏆 VSP Innovation Challenge 2024 🏆 be-advanced Team of the Year 2023 🏆 Wearable Technologies Innovation World Cup Winner 2023 🏆 Ypsomed Innovation Award 2022 🚀 The Eddies 2024 🚀 MassChallenge 2023 🚀 Massachusettes Innovation Network, Global Eddies 2023 🚀 IMD Startup Competition 2022/23 𝘋𝘐𝘚𝘊𝘓𝘈𝘐𝘔𝘌𝘙: 𝘛𝘏𝘐𝘚 𝘊𝘖𝘕𝘛𝘌𝘕𝘛 𝘐𝘚 𝘕𝘖𝘛 𝘔𝘌𝘋𝘐𝘊𝘈𝘓 𝘈𝘋𝘝𝘐𝘊𝘌 𝘛𝘦𝘹𝘵, 𝘪𝘮𝘢𝘨𝘦𝘴, 𝘷𝘪𝘥𝘦𝘰𝘴, 𝘢𝘯𝘥 𝘢𝘭𝘭 𝘰𝘵𝘩𝘦𝘳 𝘤𝘰𝘯𝘵𝘦𝘯𝘵 𝘢𝘯𝘥 𝘢𝘤𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘵𝘩𝘪𝘴 𝘓𝘪𝘯𝘬𝘦𝘥𝘐𝘯 𝘱𝘢𝘨𝘦 𝘢𝘳𝘦 𝘧𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘱𝘶𝘳𝘱𝘰𝘴𝘦𝘴 𝘰𝘯𝘭𝘺, 𝘢𝘯𝘥 𝘢𝘳𝘦 𝘯𝘰𝘵 𝘪𝘯𝘵𝘦𝘯𝘥𝘦𝘥 𝘵𝘰 𝘣𝘦 𝘢 𝘴𝘶𝘣𝘴𝘵𝘪𝘵𝘶𝘵𝘦 𝘧𝘰𝘳 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘢𝘥𝘷𝘪𝘤𝘦, 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴 𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵. 𝘈𝘭𝘸𝘢𝘺𝘴 𝘴𝘦𝘦𝘬 𝘵𝘩𝘦 𝘢𝘥𝘷𝘪𝘤𝘦 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘱𝘩𝘺𝘴𝘪𝘤𝘪𝘢𝘯 𝘰𝘳 𝘰𝘵𝘩𝘦𝘳 𝘲𝘶𝘢𝘭𝘪𝘧𝘪𝘦𝘥 𝘩𝘦𝘢𝘭𝘵𝘩 𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘷𝘪𝘥𝘦𝘳 𝘸𝘪𝘵𝘩 𝘢𝘯𝘺 𝘲𝘶𝘦𝘴𝘵𝘪𝘰𝘯𝘴 𝘺𝘰𝘶 𝘮𝘢𝘺 𝘩𝘢𝘷𝘦 𝘳𝘦𝘨𝘢𝘳𝘥𝘪𝘯𝘨 𝘢 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘤𝘰𝘯𝘥𝘪𝘵𝘪𝘰𝘯 𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵.
- Website
-
https://www.machinemd.com/
Externer Link zu machineMD
- Branche
- Herstellung medizinischer Geräte
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berne, Berne
- Kunst
- Privatunternehmen
- Gegründet
- 2019
- Spezialgebiete
- Ophthalmology, Neurology, Medical Diagnostics, Telemedicine, Startup und Neuro-Ophthalmology
Orte
-
Primär
Weyermannsstrasse 36
Berne, Berne 3008, CH
-
Boston, Massachusetts, US
Beschäftigte von machineMD
Aktualisierungen
-
machineMD hat dies direkt geteilt
Commercial Executive • Scaling up Startups • Advisory Board, Mentor, Jury Member • IMD Executive MBA & Cambridge Alum
Discover how machineMD enables fast, objective, quantified assessments of the afferent and efferent visual system at the #ESCRSiNovation Day 2024! 👀🧠 𝐒𝐞𝐬𝐬𝐢𝐨𝐧 #4 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰: 𝐅𝐫𝐨𝐦 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐑𝐨𝐨𝐦 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘪𝘯𝘨 𝘥𝘢𝘵𝘢 𝘪𝘯𝘵𝘦𝘨𝘳𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘮𝘢𝘬𝘪𝘯𝘨 𝘧𝘰𝘳 𝘰𝘱𝘵𝘪𝘮𝘪𝘴𝘦𝘥 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴 🪑 Prof. Dr. Burkhard Dick & Prof. Dr. Bruce Allan 👥 Roger Zaldivar, Cathleen McCabe, Sebastiano (Seba) Leoni, Nick Curtis 💡Emerging Company Presentations: 🎤 Ran Yam, CEO & co-founder @ NovaSight 🎤 Dimitri Chernyak, COO @ Intelon Optics 🎤 John Berestka, MD, co-founder @ Lightfield Medical 🎤 Phil Norris, CCO @ machineMD 🌐 See the full program here: https://lnkd.in/g-v9xzrv The European Society of Cataract and Refractive Surgeons (ESCRS) #ESCRS2024 #medtechinnovation #neuroophthalmology
-
-
machineMD is proud to have been awarded 🥈 place in the inaugural VSP Vision Innovation Challenge. The global competition was launched by VSP Vision, the leader in delivering access to health-focused vision care and Matter Health, the premier healthcare incubator and innovation hub, with the goal to explore solutions that enhance the patient experience in eye care. machineMD was one of five finalists that had be selected from the applicant pool that received expert mentorship and exclusive resources from the VSP network. The final showcase was held on August 15th in Chicago. machineMD was able to convince the judges of its case and received an excellent second place with its pitch for its first product neos™. neos™ is a reusable medical device system available in the USA intended to present visual stimuli to both eyes individually, and measures the resulting eye movements and pupillary changes of each eye. The device, based on an industry-leading VR headset, performs an automated examination of eye movements and pupillary function, also including visual field screening. It’s a first step towards machineMD’s mission to radically improve the measurement of brain function, with a vision for a world where people receive an accurate, fast, and early diagnosis of brain disorders. #NeuroOphthalmology #Telemedicine #Opthalmology #Neurology #visioninnovation #VSP #visioncare #optometry
-
-
Initial findings from the research work using machineMD’s technology at Ruhr University Bochum, supported by the German Multiple Sclerosis Society (DMSG e.V.) 𝐎𝐜𝐮𝐥𝐨𝐦𝐨𝐭𝐨𝐫 𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐢𝐧 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐒𝐜𝐥𝐞𝐫𝐨𝐬𝐢𝐬 - 𝐚𝐧 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰 𝐚𝐧𝐝 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐦𝐞𝐭𝐡𝐨𝐝𝐬 M. Katsimpoura, J. Haselon, Rafael Klimas, Ralf Gold, Tatiana Bremova-Ertl, Jeremias Motte, Anke Salmen In clinical practice, the binocular evaluation of oculomotor disturbances is often deprioritized, considered to be both complex and time-consuming. Despite this, disturbances in eye movements, especially internuclear ophthalmoplegia (INO) and different forms of acquired nystagmus, are frequently observed in multiple sclerosis (MS) patients. Objectifying subjective visual complaints can facilitate earlier detection of oculomotor disturbances, allowing for more precise imaging diagnostics and potentially influencing therapeutic decisions. Beyond diagnosis and optimized treatment for the underlying condition, symptomatic treatment options can be provided to patients. These should be administered as individualized treatment trials under strict therapeutic monitoring, particularly given the generally low evidence base. Future technological advancements may assist in the objective assessment of oculomotor disturbances across diverse neurological disorders. #InternuclearOphthalmoplegia #Saccades #Diplopia #Nystagmus https://lnkd.in/eKBVtwe5
-
World Brain Day 2024 - Brain Health and Prevention: Protecting our future It's World Brain Day, and this year’s focus is brain health and prevention. Neurological disorders are one of the leading causes of shortened life expectancy worldwide and have a major impact on global health. Investing in early diagnosis and effective management are very important to significantly reduce the burden of these disorders Neuro-ophthalmic examinations can contribute greatly to the early detection of brain disorders. Today, these examinations are mostly performed manually and time-intensively by highly trained specialists who are in short supply. Accessible, objective, quantitative examinations are needed. This is the mission of machineMD: Together with our global network of partners and medical experts, we strive to radically improve the measurement of brain function. We believe that automated neuro-ophthalmic examinations will increase the efficiency of healthcare providers, reduce clinical errors, and aid in the early diagnosis and management of neurological and ophthalmic diseases. #NeuroOphthalmology #BrainHealth #WorldBrainDay #EarlyDiagnosis #MedTech #Innovation #StartupSwitzerland
-
-
The machineMD Inc. team is looking forward to working with experts from VSP Vision in this inaugural #InnovationChallenge! We are convinced by the focus on using the eye as a window into full-body health, and are grateful for this opportunity to embrace innovation and improve vision care.
📣 We are excited to announce the five finalists for our first VSP Vision Innovation Challenge! In partnership with #healthcare #innovation hub MATTER, the challenge is an open call for startups transforming and enhancing the eye care patient experience. Congratulations machineMD, Ophthalytics Inc, RevitalVision, Vision Science Labs, and LENS2RECYCLE! For more about the finalists and the showcase taking place on August 15 where the winner will be announced, check out the VSP Global Innovation Center's blog: https://lnkd.in/epDthXdt
-
-
Please vote for us!
We are very proud to be in the running for the TOP 100 Swiss Startups 2024. Vote now for your favorite Swiss startup: https://lnkd.in/dhN-VNNM Voting ends on July 21st. Thank you very much for your support! #SwissStartups #Innovation #TOP100SSU
machineMD AG
startup.ch
-
We are very proud to be in the running for the TOP 100 Swiss Startups 2024. Vote now for your favorite Swiss startup: https://lnkd.in/dhN-VNNM Voting ends on July 21st. Thank you very much for your support! #SwissStartups #Innovation #TOP100SSU
machineMD AG
startup.ch
-
We are pleased to announce that machineMD has partnered with VON HOFF AG to distribute neos® - the world’s first neurophthalmoscope, to ophthalmologists and optometrists in Switzerland. "Von Hoff has recognized the potential of neos® for Swiss ophthalmologists and is very well networked within the community, making them the ideal distribution partner for us." said Dominic Senn, CEO of machineMD. “This partnership is poised to significantly enhance the diagnostic capabilities available to ophthalmologists across Switzerland.” Lukas Eigenmann, CEO of Von Hoff, shared his excitement about the collaboration: "With neos®, Swiss ophthalmologists and optometrists can enhance their practice with a fast, comprehensive, automated neuro-ophthalmic exam. I believe this has the potential to improve the efficiency of clinical assessments." neos® is the world's first neurophthalmoscope and combines a high-tech VR headset with proprietary software. The device uses data from high-speed infrared eye tracking to generate user-friendly quantitative reports, stored securely on a cloud-based platform. #Opthalmology #NeuroOphthalmology #medtech #HealthTech #HealthcareInnovation #EyeCare
-
-
👣 👀 Recording digital biomarkers of people with #Parkinson’s This week the Universitätsspital Zürich hosted project partners from the University of Exeter, gaitQ and machineMD. Together, these interdisciplinary teams embark on an 18-month research project, funded from a grant awarded by Innosuisse and Innovate UK, which will record digital biomarkers from people with #Parkinson’s. The data will be used to establish patterns of behaviour and provide clinicians with insight to deliver more effective treatment plans, ultimately helping earlier detection and treatment of the condition. 🌐 Learn more: https://lnkd.in/ec_s-8-N
-